Altundag, E. M. Et Al. 2022. Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.16 , 2909-2918.

Altundag, E. M., Yilmaz, A. M., Sahin, A., & Yilmaz, B., (2022). Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.16, 2909-2918.

Altundag, Ergul Et Al. "Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines," ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.16, 2909-2918, 2022

Altundag, Ergul M. Et Al. "Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.16, pp.2909-2918, 2022

Altundag, E. M. Et Al. (2022) . "Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines." ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , vol.22, no.16, pp.2909-2918.

@article{article, author={Ergul Mutlu Altundag Et Al. }, title={Combination of Second-Generation Proteasome Inhibitor Carfilzomib with Bortezomib in Four Different Breast Cancer Cell Lines}, journal={ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY}, year=2022, pages={2909-2918} }